About
Reprogram Biosciences develops gene reprogramming immunotherapies that convert cancer cells into immune-like cells within patients to target and treat solid tumors.
Explore Reprogram Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.